Department of Obstetrics, Gynecology and Reproductive Science, University of California, San Diego, La Jolla, California.
Department of Pediatric Hematology/Oncology, University of Texas Southwestern, Dallas, Texas.
Fertil Steril. 2020 Feb;113(2):392-399. doi: 10.1016/j.fertnstert.2019.09.030.
To examine the association between prior cancer treatments, medical comorbidities, and voluntary childlessness in reproductive-age women who are survivors of cancers diagnosed as adolescents and young adults (AYA survivors).
Cross-sectional analysis.
Participants were recruited from California and Texas cancer registries, fertility preservation programs, and cancer advocacy groups.
PATIENT(S): Women (n = 413) ages 18-40 who were diagnosed with cancer between ages 15 and 35, completed primary cancer treatments, had at least one ovary, and were nulliparous.
INTERVENTION(S): Cancer treatment gonadotoxicity and medical comorbidities.
MAIN OUTCOME MEASURE(S): Voluntary childlessness.
RESULT(S): The mean age of survivors was 31.8 years (SD, 4.9) with a mean of 6.5 years (SD, 4.4) since cancer diagnosis. Breast (26%), thyroid (19%), and Hodgkin lymphoma (18%) were the most common cancers. Twenty-two percent of the cohort was voluntarily childless. Medical comorbidities, cancer diagnosis, prior surgery, prior chemotherapy, and prior gonadotoxic treatments were not significantly associated with voluntary childlessness. In adjusted analysis, survivors of older reproductive age (adjusted odds ratio = 2.97 [1.71-5.18]) and nonheterosexual participants (adjusted odds ratio = 4.71 [2.15-10.32]) were more likely to report voluntary childlessness.
CONCLUSION(S): A moderate proportion of AYA cancer survivors are voluntarily childless, but reproductive intentions were not related to cancer type or cancer treatments. AYA survivors of older age and nonheterosexual identification were more likely to be voluntarily childless. These data support assessing reproductive intentions and tailoring reproductive care such as fertility and contraception counseling that is appropriate for a survivor's intentions.
研究青少年及青年期癌症幸存者(AYA 幸存者)中,先前癌症治疗、合并症与自愿性不孕之间的关系。
横断面分析。
参与者来自加利福尼亚州和得克萨斯州癌症登记处、生育力保存计划和癌症倡导团体。
年龄在 18 至 40 岁之间,15 至 35 岁诊断出癌症,完成了主要癌症治疗,至少有一侧卵巢,且未生育过的女性(n=413)。
癌症治疗性腺毒性和合并症。
自愿性不孕。
幸存者的平均年龄为 31.8 岁(标准差,4.9),自癌症诊断以来平均 6.5 年(标准差,4.4)。最常见的癌症为乳腺癌(26%)、甲状腺癌(19%)和霍奇金淋巴瘤(18%)。该队列中有 22%的人自愿不孕。合并症、癌症诊断、先前手术、先前化疗和先前性腺毒性治疗与自愿性不孕无显著相关性。在调整分析中,年龄较大的 AYA 幸存者(调整后的优势比=2.97[1.71-5.18])和非异性恋参与者(调整后的优势比=4.71[2.15-10.32])更有可能报告自愿性不孕。
相当一部分 AYA 癌症幸存者自愿不孕,但生育意愿与癌症类型或癌症治疗无关。年龄较大的 AYA 幸存者和非异性恋身份更有可能自愿不孕。这些数据支持评估生育意愿,并为幸存者的意愿提供适当的生育和避孕咨询等生殖护理。